StockData
Outset Medical, Inc. logo

Outset Medical, Inc. (OM) stock

OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3077% below fair value
$3.16−0.23 (-6.78%)

Close on Nov 17, 2026Market cap $59.40MP/E –Yield –

Outset Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Outset Medical's operating income for the twelve months ending Jun 30, 2026 was -$66.04M. For fiscal 2025 it was -$66.71M. The highest annual figure on record is -$46.56M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$66.71M–
FY2024Dec 31, 2024-$113.38M–
FY2023Dec 31, 2023-$169.77M–
FY2022Dec 31, 2022-$161.02M–
FY2021Dec 31, 2021-$130.52M–
FY2020Dec 31, 2020-$117.47M–
FY2019Dec 31, 2019-$70.31M–
FY2018Dec 31, 2018-$46.56M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.68M–
Q1 FY2026Mar 31, 2026-$16.92M–
Q4 FY2025Dec 31, 2025-$17.63M–
Q3 FY2025Sep 30, 2025-$15.81M–
Q2 FY2025Jun 30, 2025-$16.87M–
Q1 FY2025Mar 31, 2025-$16.40M–
Q4 FY2024Dec 31, 2024-$21.86M–
Q3 FY2024Sep 30, 2024-$23.84M–
Q2 FY2024Jun 30, 2024-$30.76M–
Q1 FY2024Mar 31, 2024-$36.91M–
Q4 FY2023Dec 31, 2023-$37.35M–
Q3 FY2023Sep 30, 2023-$45.45M–
Q2 FY2023Jun 30, 2023-$43.48M–
Q1 FY2023Mar 31, 2023-$43.49M–
Q4 FY2022Dec 31, 2022-$39.82M–
Q3 FY2022Sep 30, 2022-$41.00M–
Q2 FY2022Jun 30, 2022-$43.72M–
Q1 FY2022Mar 31, 2022-$36.48M–
Q4 FY2021Dec 31, 2021-$40.80M–
Q3 FY2021Sep 30, 2021-$30.14M–
Q2 FY2021Jun 30, 2021-$29.91M–
Q1 FY2021Mar 31, 2021-$29.68M–
Q4 FY2020Dec 31, 2020-$31.62M–
Q3 FY2020Sep 30, 2020-$40.73M–
Q2 FY2020Jun 30, 2020-$24.91M–
Q1 FY2020Mar 31, 2020-$20.21M–
Q4 FY2019Dec 31, 2019-$18.57M–
Q3 FY2019Sep 30, 2019-$18.45M–

More Outset Medical figures

See a number that looks wrong?